ICU Medical Inc.
ICUI | NASDAQ
$155.22
+$2.57 (+1.68%)
At close: Sep 21, 2026, 4:00 PM ET
$155.61
+$0.39 (+0.25%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $3.82B
Enterprise Value $4.81B
Beta 0.76
Average Volume 300.79K
Shares Outstanding (Diluted) 25.04M
Shares Change YoY 1.36%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US44930G1076
Price Performance
Price Change 1M -16.0%
Price Change 3M 14.5%
Price Change 6M 18.1%
Price Change YTD 12.1%
Price Change 1Y 17.7%
Price Change 3Y 33.3%
Price Change 5Y -36.1%
1M CAGR (ann.) -8.3%
1Y CAGR (ann.) 18.2%
5Y CAGR (ann.) -9.0%
All-Time CAGR 6.8%
Valuation
PE Ratio 131.54
Forward PE 15.61
PEG Ratio 0.01
Forward PEG 11.99
PS Ratio 1.80
Forward PS 1.70
PB Ratio 1.80
P/FCF Ratio 21.50
P/Adj. FCF Ratio 30.96
P/OCF Ratio 16.43
EV/Sales 2.23
EV/EBIT 112.37
EV/EBITDA 16.17
EV/FCF 26.67
Earnings Yield 0.8%
FCF Yield 4.7%
Adj. FCF Yield 3.2%
Financial Health
Net Debt $932.9M
Total Debt $1.23B
Cash & Short-Term Investments $298.3M
Total Assets $3.97B
Current Ratio 2.43
Quick Ratio 1.21
Debt / Equity Ratio 0.59
Debt / EBITDA 4.14
Debt / FCF 6.82
OCF / Debt 0.22
Interest Coverage 1.31
Altman Z-Score 2.31
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 37.6%
Operating Profit Margin 5.0%
EBITDA Margin 13.8%
Net Profit Margin 1.4%
FCF Margin 8.4%
Adj. FCF Margin 5.8%
SBC / Revenue 1.9%
SBC Impact (per share) -30.6%
Returns
Return on Assets 0.8%
Return on Equity 1.4%
Return on Invested Capital -21.7%
Return on Capital Employed 3.1%
Return on Tangible Assets 1.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -2.0%
Revenue CAGR 5Y 11.1%
Revenue CAGR 10Y 19.5%
EPS CAGR 3Y 188.7%
EPS CAGR 5Y -24.4%
EPS CAGR 10Y -10.0%
FCF CAGR 3Y 7.9%
FCF CAGR 5Y 0.6%
FCF CAGR 10Y 13.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 106.1%
Revenue Growth Next 3Y 2.3%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $2.13
EPS Growth Est (next Q) 4.9%
Revenue Est (next Q) $552.13M
Revenue Growth Est (next Q) 2.8%
Fair Value Estimates
Graham Number $47.80
Graham Upside -69.2%
Lynch Fair Value $5.90
Lynch Upside -96.2%
Price Target $186.40
Price Target Upside 20.1%
Cash Flow
Operating Cash Flow $275.28M
Free Cash Flow $180.44M
Adj. Free Cash Flow $125.3M
FCF Per Share $6.11
OCF Per Share $9.45
OCF/S Ratio 10.9%
Income Statement
Revenue $2.16B
Gross Profit $811.16M
Operating Income $108.76M
EBITDA $297.64M
Net Income $30.09M
EPS (Diluted) $1.18
Revenue / Employee $166.1K
Profit / Employee $2.31K
Employees 13,000
Add to Watchlist
Select watchlists to add or remove ICUI